Maverick Energy Group, Ltd.
ST AUGUSTINE, FL / ACCESSWIRE / July 20, 2021 / James McCabe, President and CEO of Maverick Energy Group, Ltd. (OTC PINK:MKGP) ("Maverick"), an independent oil and gas exploration company, announced today that Maverick/USR have signed a binding LOI and will jointly develop Martin Foree Operating (MFO) wells using USR Ultra Short Radius Horizontal Drilling Technology.
Maverick/USR targeted zones are the San Andres and Grayburg reservoirs which have yielded approximately 42% (9.8 billion barrels) of the total cumulative production of oil from the Permian Basin of West Texas. Major San Andres and Grayburg reservoirs are estimated to contain 8.7 billion barrels of unrecovered mobile oil. Approximately 900 million barrels of unrecovered mobile oil lie within a northwest-trending group of fields including McElroy, Dune, Waddell, Jordan, and Penwell on the eastern margin of the Central Basin Platform according to a study performed in April 2012 by the United States Geological Survey (USGS).
Maverick/ USR/ Martin Foree Operating (MFO) believe the Dune Field, which is 15 miles south of Odessa, Texas in Crane County, has significant quantities of mobile oil remaining after primary and secondary recovery. The Dune Field was discovered in 1938 and developed with 900 conventional vertical wells.
Maverick/USR and MFO's first targeted producing formation is the San Andres dolomite which is a 200' thick highly fractured carbonate oil reservoir at a depth of 3,300' that contains an estimated 590MMbbls of original oil in place. Approximately 177MMbbls have been recovered from the vertical wells representing roughly 30% of the original oil in place.
Various methods including acid treatments, water floods and increased well density have been used to improve oil recovery from this oil rich but tight rock. However, no San Andres horizontal wells have been drilled to recover additional oil reserves in the undrained fracture systems in this area. A few horizontal wells have been drilled in the overlying Grayburg with initial production rates of +/-200BOPD.
In the 1950's Mobil Oil Corporation was active in the Dune Oil Field. In 1954 they formed the "Mobil University Unit 15/16" and worked to improve oil recovery by drilling additional wells on 20 acres spacing in conjunction with water flooding. Mobil ultimately drilled 101 wells in the 1,280 acres unit and produced 13.8 million barrels of oil from this unit.
The MFO 960 acres in the "UTEX Lease" is Dune Field acreage that adjoins and is up dip to the Mobil 15/16 Unit. Like most of the Dune Field we believe that this acreage has not been properly exploited. Ultra-Short Radius (USR) horizontal drilling technology will be used to unlock the oil stranded between vertical wells without drilling additional wells. The first candidate well for re-entry and sidetrack is DD #6. We believe that the success of the DD #6 well will make hundreds of wells readily available for re-entry to the Maverick/USR/MFO group.
Highlights of the Maverick/USR/MFO Dune Field development are: 960 contiguous acres; 27 existing wellbores; two saltwater injection wells; gas gathering system and electrical throughout the property.
Highlights of the Dune Field Geology and Reservoir are: 200' thick San Andres Formation; high formation oil saturation; formation porosity of 10-18%; natural fractures and a current bottom hole pressure of 500ps, which is 30-40% of original bottom hole pressure.
The Dune Field engineering studies estimate the field to have 590 million barrels of oil originally in place of which 177 million barrels have been produced to date. Unrecovered remaining moveable oil is approximately 413 million barrels. Vertical wells in the Dune Field have produced on average 196,666 barrels of oil. An integrated geological and reservoir study has indicated that approximately 10,000,000 barrels of unrecovered oil is in an area of only one square mile.
"Maverick has made significant progress in establishing industry relationships and implementing its unique business model with the strong relationship with USR. With the Dune Field project, Maverick will now participate in a world class oil field development that can be repeated many times over with USR and MFO," said James McCabe, CEO Maverick Energy Group, Ltd.
About Maverick Energy Group
Maverick Energy Group LTD is a crude oil and natural gas acquisition, production, exploration, and horizontal drilling development company focusing on select areas of North America. Maverick believes that its access to patented and proprietary horizontal production enhancement technologies facilitates the rapid accumulation of valuable oil and gas assets, while at the same time greatly improving the rate of production and lifetime potential of these properties.
Company Website: www.maverickeg.com
Safe Harbor Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimates," "projects," "intends," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, butare not limited to, the Company's ability to successfully execute its expanded business strategy, including by entering into definitive agreements with suppliers, commercial partners, and customers; general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, regulatory requirements, and the ability to meet them, government agency rules and changes, and various other factors beyond the Company's control.
CONTACT:
Maverick Energy Group, Ltd.
investors@maverickeg.com
SOURCE: Maverick Energy Group, Ltd.
View source version on accesswire.com:
https://www.accesswire.com/656208/Maverick-Energy-Group-LTD-Announcing-Permian-Basin-Agreement-in-Crane-County-Texas-7202021
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Datavault AI Announces Target to Expand its AI Driven Data Monetization Network to Over 100 Cities Across the Contiguous United States, Starting in the Second Half of 2026 with Corresponding 2027 Revenue Target12.1.2026 14:05:00 CET | Press release
Datavault AI expects to have a fully operational network with over 100 nodes across 33 cities nationwide, generating revenue in the second half of 2026. Target revenue for this project is $400 to $500 million, thereby supporting the $200 million revenue guidance for 2026. With the full deployment of Datavault AI's nodes across 100+ cities throughout the United States, the 2027 revenue target is $2.0 to $3.0 billion for 2027. New York and Philadelphia edge network activation positions Datavault AI to potentially capture a significant share of the insurance and financial sectors, the healthcare industry, and enterprise opportunities. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (Nasdaq:DVLT), a leader in AI-driven data valuation, monetization, credentialing, and digital engagement technologies, today highlighted the strategic importance of its New York and Philadelphia edge network deployment with Available Infrastructure's SanQtum AI platform. This
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC12.1.2026 13:00:00 CET | Press release
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ACCESS Newswire / January 12, 2026 / OBI Pharma (4174.TWO) announced that it has entered into a commercial license agreement with TegMine Therapeutics, Inc. (TegMine), a San Francisco-based biopharma focused on developing antibodies targeting cancer-associated glycans and glycoproteins, for a glycan-targeting ADC. Under the terms of the agreement, OBI is eligible to receive an upfront payment as well as development and commercial milestones. Following product launch, OBI will also receive royalties based on a tiered percentage of annual net sales. While the detailed financial terms are not disclosed in accordance with the confidentiality provisions, the overall deal economics are broadly comparable to those of recent similar licensing transactions in the market. TegMine will obtain the exclusive global rights to develop and commercialize the ADC under the license agreemen
Charlie's Holdings (OTCQB:CHUC) Signs Agreement with IKE Tech to Commercialize Transformational Age-Gated Vapes that Will Address FDA Concerns Related to Youth Access12.1.2026 12:00:00 CET | Press release
SBX Product Line Will Feature First-Ever AI-Powered Blockchain-Based Age-Gating System for Vape Products IKE's patented biometric BLE Bluetooth chip and blockchain-based app will enable Charlie's to ensure that underage individuals will not be able to activate or utilize the Company's age-gated products. The IKE Licensing Agreement provides CHUC with a first mover advantage in youth access prevention (one of the FDA's top priorities) and a three-year exclusivity period for age-gated nicotine analogue products. Charlie's will test market the IKE age-gating system this spring with the Company's popular SBX nicotine analogue product line; simultaneously, Charlie's intends to incorporate the revolutionary technology into its PACHA branded Electronic Nicotine Delivery Systems (ENDS). COSTA MESA, CA / ACCESS Newswire / January 12, 2026 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today reported that the Compan
Datavault AI Celebrates Successful Completion of Dream Bowl XIV, Pioneering Blockchain Innovation in Sports Entertainment12.1.2026 12:00:00 CET | Press release
On January 10, 2026, a few dozen of NFL Alumni Greats (click here for a list of participating athletes) live-autographed 100 Footballs (click here to view the autographed NFL Alumni Footballs) and 500 Jerseys (click here to view the autographed NFL Alumni Jerseys); Starting on February 1, 2026, these special, one-time, live-autographed memorabilia items are to be given away by lottery to eligible holders of Dream Bowl Meme Coin I tokens and, following their distribution date (currently set for February 21, 2026), Dream Bowl Meme Coin II tokens and will be tradable on the upcoming International NIL Exchange; $25,000 E-Sports Scholarships Raised by Sponsors were Given to Dream Bowl Madden and Team E-Sports Champions; and 70 Student Star Athletes Showcased their Talent to USFL, NFL and European League Scouts (click here to view the Special Dream Bowl XIV Participants' Jerseys). PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI
PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference9.1.2026 18:35:00 CET | Press release
MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company's Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company's lead asset PRO CAR - 201A, a STEAP1 directed CAR T cell that is currently in the clinic as a first-in-human phase 1 trial for the treatment of metastatic castration-resistant prostate cancer (mCRPC), at Biotech Showcase 2026 in San Francisco, California on Monday, January 12, 2025 at 11:15 am PST at the Franciscan D (Ballroom Level). About PromiCell, Inc. PromiCell, is a clinical-stage cellular immunotherapy company with product candidates representing highly differentiated and novel CAR T and TCR T platforms to be developed across separate solid and hematologic types of cancer. Our pipeline of innovative products includes STEAP 1 CAR T cells, HA-1 T
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
